companydata.dkSYNACT PHARMA ApS: Financial statements 2015
CVR: 34459975
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -309,046 and a net result of DKK -782,555 compared with DKK -768,256 the year before. Equity amounted to DKK -3,893,006.
- Gross Profit
- -309,046 kr.
- Profit/Loss
- -782,555 kr.
- Equity
- -3,893,006 kr.
- Total Assets
- 305,946 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -309 t. | -783 t. | -3.9 mio. | - |
| 2014 | - | -343 t. | -768 t. | -3.1 mio. | - |
| 2013 | - | -953 t. | -1.1 mio. | -2.3 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of August 17, 2015, Thomas Engelbrecht Nordkild Jonassen has joined the board of directors of SYNACT PHARMA ApS.
As of August 17, 2015, Jeppe Øvli Øvlesen is registered as adm. dir. of SYNACT PHARMA ApS.
As of August 17, 2015, Sigbjørn Georg Nielsen Kjærgård has stepped down as adm. dir. of SYNACT PHARMA ApS.
SYNACT PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -343,449, and the net result was DKK -768,256.
As of February 16, 2015, Otto Bjerg Hausgaard has joined the board of directors of SYNACT PHARMA ApS.
As of February 16, 2015, Uli Alf Hacksell has left the board of directors of SYNACT PHARMA ApS.
As of February 9, 2015, Jørn Frederik Falch has left the board of directors of SYNACT PHARMA ApS.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity amounted to DKK 20,295,649.